This hypothesis has no description yet.
Tau-first AD pathology
market 50% proposed
Composite
—
Novelty
—
Feasibility
—
Impact
—
Mechanistic
—
Druggability
—
Safety
—
Confidence
—
This hypothesis has no description yet.